Efficacy and tolerability of tropisetron in the prevention of cisplatin- induced nausea and vomiting in advanced non-small cell lung cancer

Acta Oncologica

Volumn 39, Issue 2, 2000, Pages 221-224

  Thongprasert, Sumitra ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; TROPISETRON;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

EID: 0034111361     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600430815     Document Type: Article

References (8)

1. Lee CR, Plosker GL, McTavish D. Tropisetron: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential as an antiemetic. Drugs 1993; 46: 925-43.
2. Doliotti L, Antonacci RA, Paze E, et al. Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. Drugs 1992; 43 (Suppl 3): 6-10.
3. Bruntsch U, Rufenacht E, Parker I, et al. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy. Ann Oncol 1993; 4 (Suppl 3): S25-9.
4. Sorbe B. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. Ann Oncol 1993; 4 (Suppl 3): 39.
5. 3-receptor antagonist versus a standard antiemetic regimen of dexamethasone and metoclopramide in the treatment of cisplatin-containing chemotherapy. Drug Invest 1993; 6: 162-9.
6. Sorbe BG, Hallen C, Frankendal Bo. An open, randomised study comparing the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer Chemother Pharmacol 1994; 33: 298-302.
7. Buntsch U, Dreschier S, Seeber S, et al. Optimal treatment with tropisetron (Tro) in acute and delayed chemotherapy-induced emesis (CIE). Eur J Cancer 1993; 29A (Suppl 6): S211.
8. 3 receptor antagonist, with a metoclopramide containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer 1994; 73: 445-54.